- Home
- ZNTL vs KWY Comparison
ZNTL vs KWY Comparison
Compare ZNTL & KWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZNTL | KWY |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 289.0M | 293.1M |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ZNTL | KWY |
|---|---|---|
| Price | $4.11 | $9.84 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.60 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 63.7K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $134,996,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 23.42 |
| 52 Week Low | $1.21 | $8.41 |
| 52 Week High | $6.95 | $11.36 |
Technical Indicators
Market Signals| Indicator | ZNTL | KWY |
|---|---|---|
| Relative Strength Index (RSI) | 41.97 | 54.94 |
| Support Level | $3.53 | $8.58 |
| Resistance Level | $4.23 | $10.77 |
| Average True Range (ATR) | 0.35 | 0.48 |
| MACD | -0.09 | 0.15 |
| Stochastic Oscillator | 13.60 | 77.51 |
Price Performance
Historical ComparisonAbout ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About KWY Kingsway Corporation Common Stock
Kingsway Corp is a U.S.-based company employing the Search Fund model to acquire and build great businesses. The company owns and operates a collection of B2B and B2C services companies that are asset-light, growing, profitable, and that have recurring revenues. It seeks to compound long-term shareholder value on a per share basis via its decentralized management model, its talented team of operators, and its tax-advantaged corporate structure.